Benefiting Humanity

Expanding the Limits of the Possible

Expanding the Limits of the Possible

07.11.2022

Benefiting Humanity

The Weizmann Institute of Science confers nine honorary PhDs

A glimpse into Bina offices

Your Applied Research Journey Starts Here

31.10.2022

Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

Equipped with a team of industry experts, innovation hub Bina invites Weizmann Institute scientists to examine the applicative potential of their...

Patterns of epigenetic markers revealed by EPINUC on blood nucleosomes (bright-red dots)

Putting Liquid Biopsies on Solid Ground: Cancer Diagnosis from a Milliliter of Blood

08.09.2022

Cancer, Personalized Medicine, Disease, Drugs & Diagnostics, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

If larger studies confirm the results of a Weizmann Institute innovation, diagnosing cancer may one day be as easy as taking blood

Prof. Yosef Shaul. A lifelong quest

Spiking the Particle

25.04.2022

Viruses & Microorganisms, Disease, Drugs & Diagnostics, Technology & Applications, Yeda Technology Transfer, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

FDA approves third-generation hepatitis B vaccine based on Weizmann research

Rendering of the building that will house the Azrieli Institute for Brain and Neural Sciences on the Weizmann Institute of Science campus, Skorka Architects

The Weizmann Institute of Science Receives $50 Million from the Azrieli Foundation to Help Humanity Unlock the Mysteries of the Brain

09.11.2021

Brain & Behavior, Benefiting Humanity

This donation – among the largest of its kind for the Foundation – will establish the Azrieli Institute for Brain and Neural Sciences at the Weizmann...

Dr. Nir London

Global Initiative to Rapidly Develop a Safe, Globally Accessible and Affordable COVID-19 Antiviral Pill

29.09.2021

Structural Biology, Disease, Drugs & Diagnostics, Benefiting Humanity, Diagnostic Techniques and Drugs

COVID Moonshot – the world's largest open-science drug discovery effort – aims to identify pre-clinical candidate molecules, with first clinical...

MBZUAI President, Professor Eric Xing and President of the Weizmann Institute, Professor Alon Chen in Abu Dhabi

A Senior Delegation from the Weizmann Institute of Science Visits MBZUAI Campus in Abu Dhabi

03.05.2021

Math & Computer Science, Computer Vision, Bioinformatics and Computational Biology, Astrophysics, Personalized Medicine, Genetics, Technology & Applications, Benefiting Humanity, Biotechnology

The two parties discussed their new collaboration initiative to advance the field of artificial intelligence research

Prof. Meir Wilchek

An Affinity for Science

11.03.2021

Organic Chemistry, Structural Biology, Biochemistry, Benefiting Humanity, Biotechnology, Diagnostic Techniques and Drugs

From refugee child to world-renowned scientist, Prof. Meir Wilchek opened doors to new techniques in research and industry around the globe

Our Customers Want Yellow Bananas

Our Customers Want Yellow Bananas

04.03.2021

Yeda Technology Transfer, Benefiting Humanity

An interview with the CEO of Yeda, Dr. Opher Shapira, who took office in the midst of a pandemic and radical changes in the global economy

Weizmann Institute of Science Ranked Eighth in the World for Research Quality

Weizmann Institute of Science Ranked Eighth in the World for Research Quality

09.11.2020

Benefiting Humanity

In Life and Earth Sciences, the Institute was ranked fourth

Pages

Top Stories

Tiny droplets formed by peptides and RNA, viewed under a microscope

Life’s Mysteries Converge in a Droplet

Prof. Michael Fainzilber

Prof. Michael Fainzilber

Prof. Nachum Ulanovsky

Prof. Nachum Ulanovsky

Eliran Kirschenbaum

Eliran Kirschenbaum

Press Releases

Expanding the Limits of the Possible

Human Tumors Are Prized Real Estate for Fungi, Study Finds

Putting Liquid Biopsies on Solid Ground: Cancer Diagnosis from a Milliliter of Blood